{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:54:06Z","timestamp":1781632446883,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["2015-703549"],"award-info":[{"award-number":["2015-703549"]}],"id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In October 2018, Canada legalized non-medical cannabis, increasing accessibility nationwide. Although a separate medical cannabis framework exists, many individuals with cancer may now obtain cannabis through non-medical channels rather than through the medical system. This shift raises questions about how legalization has influenced patients\u2019 attitudes and preferences regarding the use of cannabis to manage cancer-related symptoms and treatment side effects. We aimed to determine individuals\u2019 preferences for using cannabis as a complementary therapy in cancer survivorship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Members of a Canadian research panel completed a discrete choice experiment (DCE) to assess preferences for medicinal cannabis. Respondents completed 12 choice sets, each consisting of two health states described by seven attributes identified from previous qualitative work, as well as an opt-out option. The seven attributes were cannabis effectiveness, ability to perform everyday activities, chance of unwanted side effects, opinions of family and friends about cannabis, doctor\u2019s opinion of cannabis, access to cannabis, and out-of-pocket cost. Each attribute had three or four levels. DCE responses were analyzed using an error-component mixed logit regression model to estimate the relative attribute importance and willingness-to-pay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The dataset included 1,089 respondents who completed at least one choice set. Of these, 61.5% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009670) reported no experience with cancer, and 35.5% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009387) had some experience with cannabis. Analysis of the DCE responses demonstrated that respondents preferred the effective management of cancer symptoms and the ability to perform everyday activities. Respondents expressed disutility for unwanted side effects resulting from cannabis use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>To our knowledge, this is the first study to elicit general population preferences for medicinal cannabis in the context of cancer survivorship. Insights from these preferences may inform policy and priority-setting to support equitable access to medical cannabis for symptom management improved quality of life among individuals with cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-026-00392-1","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:05:13Z","timestamp":1769421913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using a discrete choice experiment to estimate individual preferences to medicate cancer-related symptoms with cannabis"],"prefix":"10.1186","volume":"8","author":[{"given":"Helen","family":"McTaggart-Cowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.N.","family":"Raymakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Izadi-Najafabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colene","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"25","key":"392_CR1","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1056\/NEJMra1712502","volume":"379","author":"CL Shapiro","year":"2018","unstructured":"Shapiro CL. Cancer survivorship. N Engl J Med. 2018;379(25):2438\u201350.","journal-title":"N Engl J Med"},{"issue":"4","key":"392_CR2","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.3390\/curroncol29040218","volume":"29","author":"C Link","year":"2022","unstructured":"Link C, DeIure A, Watson L. Understanding the post-treatment concerns of cancer survivors with five common cancers: exploring the Alberta results from the pan-Canadian transitions study. Curr Oncol. 2022;29(4):2662\u201380.","journal-title":"Curr Oncol"},{"issue":"8","key":"392_CR3","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/ijc.34152","volume":"151","author":"ME Schmidt","year":"2022","unstructured":"Schmidt ME, Goldschmidt S, Hermann S, Steindorf K. Late effects, long-term problems and unmet needs of cancer survivors. Int J Cancer. 2022;151(8):1280\u201390.","journal-title":"Int J Cancer"},{"issue":"1","key":"392_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/SPC.0000000000000692","volume":"18","author":"S Faithfull","year":"2024","unstructured":"Faithfull S, Greenfield D. Cancer survivor late-effects, chronic health problems after cancer treatment: what\u2019s the evidence from population and registry data and where are the gaps? Curr Opin Support Palliat Care. 2024;18(1):55.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"392_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11912-019-0757-7","volume":"21","author":"G Steele","year":"2019","unstructured":"Steele G, Arneson T, Zylla D. A comprehensive review of cannabis in patients with cancer: availability in the USA, general Efficacy, and safety. Curr Oncol Rep. 2019;21(1):10.","journal-title":"Curr Oncol Rep"},{"key":"392_CR6","unstructured":"National Academies of Sciences, Engineering, and, Medicine H, Division M, Board on Population Health and Public Health Practice, Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research [Internet]. Washington (DC): National Academies Press (US); 2017 [cited 2023 July 10]. (The National Academies Collection: Reports funded by National Institutes of Health). Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK423845\/"},{"issue":"Suppl 2","key":"392_CR7","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.21037\/apm.2017.08.05","volume":"6","author":"A Blake","year":"2017","unstructured":"Blake A, Wan BA, Malek L, DeAngelis C, Diaz P, Lao N, et al. A selective review of medical cannabis in cancer pain management. Ann Palliat Med. 2017;6(Suppl 2):S215\u201322.","journal-title":"Ann Palliat Med"},{"key":"392_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2019.102204","volume":"47","author":"D Victorson","year":"2019","unstructured":"Victorson D, McMahon M, Horowitz B, Glickson S, Parker B, Mendoza-Temple L. Exploring cancer survivors\u2019 attitudes, perceptions, and concerns about using medical cannabis for symptom and side effect management: a qualitative focus group study. Complement Ther Med. 2019;47:102204.","journal-title":"Complement Ther Med"},{"issue":"10","key":"392_CR9","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.3390\/biomedicines11102630","volume":"11","author":"ZJ Leinen","year":"2023","unstructured":"Leinen ZJ, Mohan R, Premadasa LS, Acharya A, Mohan M, Byrareddy SN. Therapeutic potential of cannabis: A comprehensive review of current and future applications. Biomedicines. 2023;11(10):2630.","journal-title":"Biomedicines"},{"key":"392_CR10","doi-asserted-by":"publisher","unstructured":"Cannabis and Cannabinoids in Adults With Cancer. ASCO Guideline | Journal of Clinical Oncology [Internet]. [cited 2025 Oct 24]. Available from: https:\/\/doi.org\/10.1200\/JCO.23.02596","DOI":"10.1200\/JCO.23.02596"},{"issue":"1","key":"392_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/ijms25010074","volume":"25","author":"PP Bathula","year":"2023","unstructured":"Bathula PP, Maciver MB. Cannabinoids in treating Chemotherapy-Induced nausea and Vomiting, Cancer-Associated Pain, and tumor growth. Int J Mol Sci. 2023;25(1):74.","journal-title":"Int J Mol Sci"},{"key":"392_CR12","unstructured":"National Academies of Sciences E, Division H, Practice M, on PH B, Agenda PH. C on the HE of MAER and R. Therapeutic Effects of Cannabis and Cannabinoids. In: The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research [Internet]. National Academies Press (US); 2017 [cited 2025 Oct 24]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK425767\/"},{"issue":"3","key":"392_CR13","doi-asserted-by":"publisher","first-page":"e0271079","DOI":"10.1371\/journal.pone.0271079","volume":"18","author":"M Shim","year":"2023","unstructured":"Shim M, Nguyen H, Grootendorst P. Lessons from 20 years of medical cannabis use in Canada. PLoS One. 2023;18(3):e0271079.","journal-title":"PLoS One"},{"issue":"1","key":"392_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/cam4.3536","volume":"10","author":"H McTaggart-Cowan","year":"2021","unstructured":"McTaggart-Cowan H, Bentley C, Raymakers A, Metcalfe R, Hawley P, Peacock S. Understanding cancer survivors\u2019 reasons to medicate with cannabis: a qualitative study based on the theory of planned behavior. Cancer Med. 2021;10(1):396\u2013404.","journal-title":"Cancer Med"},{"issue":"4","key":"392_CR15","first-page":"213","volume":"2","author":"JFP Bridges","year":"2003","unstructured":"Bridges JFP. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy. 2003;2(4):213\u201324.","journal-title":"Appl Health Econ Health Policy"},{"issue":"6","key":"392_CR16","doi-asserted-by":"publisher","first-page":"E190","DOI":"10.1503\/cmaj.140697","volume":"187","author":"DA Regier","year":"2015","unstructured":"Regier DA, Peacock SJ, Pataky R, van der Hoek K, Jarvik GP, Hoch J, et al. Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment. CMAJ. 2015;187(6):E190\u20137.","journal-title":"CMAJ"},{"issue":"4","key":"392_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","volume":"19","author":"AB Hauber","year":"2016","unstructured":"Hauber AB, Gonz\u00e1lez JM, Groothuis-Oudshoorn CGM, Prior T, Marshall DA, Cunningham C, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19(4):300\u201315.","journal-title":"Value Health"},{"key":"392_CR18","doi-asserted-by":"publisher","unstructured":"Neumann PJ, Russell LB, Siegel JE, Prosser LA, Krahn M, Mandelblatt JS et al. Using Cost-Effectiveness Analysis in Health and Medicine: Experiences since the Original Panel. In: Neumann PJ, Ganiats TG, Russell LB, Sanders GD, Siegel JE, editors. Cost-Effectiveness in Health and Medicine [Internet]. Oxford University Press; 2016 [cited 2023 July 10]. p. 0. Available from: https:\/\/doi.org\/10.1093\/acprof:oso\/9780190492939.003.0001","DOI":"10.1093\/acprof:oso\/9780190492939.003.0001"},{"key":"392_CR19","unstructured":"Canada H. Understanding the Access to Cannabis for Medical Purposes Regulations [Internet]. 2016 [cited 2024 May 27]. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/publications\/drugs-health-products\/understanding-new-access-to-cannabis-for-medical-purposes-regulations.html"},{"key":"392_CR20","doi-asserted-by":"publisher","unstructured":"Ryan M, Gerard K, Amaya-Amaya M,Using Discrete Choice Experiments to Value Health and Health Care [Internet]. Dordrecht: Springer Netherlands;, Bateman IJ, editors. The Economics of Non-Market Goods and Resources; vol. 11). Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-1-4020-5753-3","DOI":"10.1007\/978-1-4020-5753-3"},{"issue":"9","key":"392_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40273-014-0170-x","volume":"32","author":"MD Clark","year":"2014","unstructured":"Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW. Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics. 2014;32(9):883\u2013902.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"392_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hec.1697","volume":"21","author":"EW de Bekker-Grob","year":"2012","unstructured":"de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21(2):145\u201372.","journal-title":"Health Econ"},{"issue":"2","key":"392_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40273-018-0734-2","volume":"37","author":"V Soekhai","year":"2019","unstructured":"Soekhai V, de Bekker-Grob EW, Ellis AR, Vass CM. Discrete choice experiments in health economics: Past, present and future. PharmacoEconomics. 2019;37(2):201\u201326.","journal-title":"PharmacoEconomics"},{"key":"392_CR24","volume-title":"Stata statistical software: release 16. College station","author":"StataCorp","year":"2019","unstructured":"StataCorp. Stata statistical software: release 16. College station. TX: StataCorp LLC; 2019."},{"key":"392_CR25","doi-asserted-by":"crossref","unstructured":"Kuhfeld WF, Tobias RD, Garratt M. Efficient experimental design with marketing-research applications. J Mark Res. 1994;31:243\u201364.","DOI":"10.2307\/3151882"},{"issue":"4","key":"392_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s40271-021-00567-3","volume":"15","author":"C Bentley","year":"2022","unstructured":"Bentley C, Izadi-Najafabadi S, Raymakers A, McTaggart-Cowan H. Qualitative research informing a preference study on selecting cannabis for cancer survivor symptom management: design of a discrete choice experiment. Patient. 2022;15(4):497\u2013507.","journal-title":"Patient"},{"issue":"2","key":"392_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0749-5978(91)90020-T","volume":"50","author":"I Ajzen","year":"1991","unstructured":"Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179\u2013211.","journal-title":"Organ Behav Hum Decis Process"},{"key":"392_CR28","unstructured":"Government of Canada SC. Cannabis consumer prices [Internet]. 2018 [cited 2025 Oct 28]. Available from: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1810021101"},{"key":"392_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.addbeh.2018.12.001","volume":"90","author":"S Mahamad","year":"2019","unstructured":"Mahamad S, Hammond D. Retail price and availability of illicit cannabis in Canada. Addict Behav. 2019;90:402\u20138.","journal-title":"Addict Behav"},{"issue":"4","key":"392_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/dar.13069","volume":"39","author":"S Mahamad","year":"2020","unstructured":"Mahamad S, Wadsworth E, Rynard V, Goodman S, Hammond D. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation. Drug Alcohol Rev. 2020;39(4):337\u201346.","journal-title":"Drug Alcohol Rev"},{"key":"392_CR31","unstructured":"Mustel Group | Mustel Group [Internet]. [cited 2023 July 10]. Available from: https:\/\/mustelgroup.com\/"},{"key":"392_CR32","unstructured":"Canada S. 2016 Census of Population [Internet]. 2021 [cited 2023 July 10]. Available from: https:\/\/www12.statcan.gc.ca\/census-recensement\/2016\/index-eng.cfm"},{"issue":"6","key":"392_CR33","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1177\/0272989X13503499","volume":"34","author":"R Norman","year":"2014","unstructured":"Norman R, Viney R, Brazier J, Burgess L, Cronin P, King M, et al. Valuing SF-6D health States using a discrete choice experiment. Med Decis Mak. 2014;34(6):773\u201386.","journal-title":"Med Decis Mak"},{"issue":"8","key":"392_CR34","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00019053-200826080-00004","volume":"26","author":"E Lancsar","year":"2008","unstructured":"Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user\u2019s guide. Pharmacoeconomics. 2008;26(8):661\u201377.","journal-title":"Pharmacoeconomics"},{"key":"392_CR35","unstructured":"Train KE. Discrete Choice Methods with Simulation [Internet]. 2nd ed. Cambridge: Cambridge University Press; 2009 [cited 2023 July 10]. Available from: https:\/\/www.cambridge.org\/core\/books\/discrete-choice-methods-with-simulation\/49CABD00F3DDDA088A8FBFAAAD7E9546"},{"issue":"1","key":"392_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jval.2017.07.001","volume":"21","author":"EM Janssen","year":"2018","unstructured":"Janssen EM, Hauber AB, Bridges JFP. Conducting a discrete-choice experiment study following recommendations for good research practices: an application for eliciting patient preferences for diabetes treatments. Value Health. 2018;21(1):59\u201368.","journal-title":"Value Health"},{"issue":"3","key":"392_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.econlet.2010.11.033","volume":"110","author":"AR Hole","year":"2011","unstructured":"Hole AR. A discrete choice model with endogenous attribute attendance. Econ Lett. 2011;110(3):203\u20135.","journal-title":"Econ Lett"},{"key":"392_CR38","unstructured":"Drummond MF, Sculpher M, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Fourth edition. Oxford New York: Oxford University Press; 2015. 445 p."},{"issue":"4","key":"392_CR39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0277-9536(98)00374-8","volume":"48","author":"M Ryan","year":"1999","unstructured":"Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med. 1999;48(4):535\u201346.","journal-title":"Soc Sci Med"},{"issue":"5","key":"392_CR40","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.amepre.2023.12.013","volume":"66","author":"L Winfield-Ward","year":"2024","unstructured":"Winfield-Ward L, Hammond D. Social norms for cannabis use after nonmedical legalization in Canada. Am J Prev Med. 2024;66(5):809\u201318.","journal-title":"Am J Prev Med"},{"key":"392_CR41","doi-asserted-by":"crossref","unstructured":"Gething K, Erku D, Scuffham P. Stakeholders\u2019 decisions and preferences for the provision and use of medicinal cannabis: a scoping review. Cannabis Cannabinoid Res. 2023;8(6):986\u201398.","DOI":"10.1089\/can.2022.0115"},{"key":"392_CR42","doi-asserted-by":"crossref","unstructured":"Fricker RD, London England EC1Y 1SP United Kingdom. Sampling Methods for Web and E-mail Surveys. In: The SAGE Handbook of Online Research Methods [Internet]. 1 Oliver\u2019s Yard, 55 City Road, : SAGE Publications, Ltd; 2008 [cited 2023 July 11]. pp. 195\u2013216. Available from: https:\/\/methods.sagepub.com\/book\/the-sage-handbook-of-online-research-methods\/n11.xml","DOI":"10.4135\/9780857020055.n11"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-026-00392-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00392-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00392-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:08:58Z","timestamp":1781629738000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42238-026-00392-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1186\/s42238-026-00392-1","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Research Ethics Board at BC Cancer (H19-01489). All study participants provided their informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}